Glaucoma Surgery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Punches, USC marker, USC planner, USC shaver, forceps, algerbrush, probes, diamond knives, Glaucoma Drainage Device, Laser System, Others), By Surgery Method (Traditional glaucoma surgery, Minimal invasive glaucoma surgery, Laser surgery), By End Use (Hospitals, Ophthalmic clinics, Others), By Region & Competition, 2020-2030F

June 2025 | 185 pages | ID: G24C51FCDBF5EN
TechSci Research

US$ 4,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Market Overview

The Global Glaucoma Surgery Devices Market was valued at USD 1.44 billion in 2024 and is anticipated to grow at a CAGR of 5.14% through 2030. This growth is primarily driven by the rising global incidence of glaucoma, a chronic eye disease that is among the leading causes of irreversible blindness. With increased awareness of early detection and treatment options, there is a growing preference for surgical interventions, particularly for patients who do not respond to medications. According to the World Health Organization (WHO) 2023 report, more than 2.2 billion people suffer from some form of vision impairment globally, underscoring the critical need for timely eye care and effective treatments. These trends highlight the expanding role of advanced surgical devices in preventing avoidable vision loss and improving quality of life for affected individuals.

Key Market Drivers

Increasing Geriatric Population

The expanding global geriatric population is a major driver of the Global Glaucoma Surgery Devices Market. According to WHO, the proportion of people aged 65 and above rose from 5.5% in 1974 to 10.3% in 2024 and is projected to reach 20.7% by 2074. Since glaucoma predominantly affects older adults, the growing elderly demographic is directly linked to an increased prevalence of this condition. As life expectancy continues to rise, so does the number of individuals at risk for glaucoma, intensifying the need for early diagnosis and surgical intervention. Additionally, aging populations in both developed and emerging markets are experiencing higher healthcare access, resulting in more frequent eye screenings and subsequent treatments. Innovations in surgical techniques, particularly the rise of micro-invasive glaucoma surgery (MIGS), are also enabling safer, more effective solutions tailored to elderly patients. As this population segment expands, demand for reliable glaucoma surgery devices is expected to remain strong.

Key Market Challenges

Availability of Alternative Treatment Methods

The presence of alternative treatment methods presents a notable challenge to the growth of the Global Glaucoma Surgery Devices Market. Non-surgical interventions—particularly pharmaceutical eye drops—remain widely used due to their non-invasive nature and patient familiarity. Laser therapies, such as selective laser trabeculoplasty (SLT) and laser peripheral iridotomy (LPI), offer additional less-invasive options with shorter recovery periods, making them appealing to many patients. Furthermore, minimally invasive glaucoma surgery (MIGS) blurs the line between medical and surgical treatments, offering safer procedures that can be performed alongside cataract surgeries. These alternatives often serve as the first line of treatment, especially in early-stage cases, limiting the number of patients opting for traditional surgical devices. Factors such as patient age, comorbidities, and treatment affordability further influence the decision, often leading healthcare professionals to recommend less invasive measures initially.

Key Market Trends

Minimally Invasive Glaucoma Surgery (MIGS) Dominance

The rising adoption of Minimally Invasive Glaucoma Surgery (MIGS) is a pivotal trend reshaping the Global Glaucoma Surgery Devices Market. MIGS procedures are gaining popularity due to their less invasive approach, which involves smaller incisions, faster recovery, and reduced postoperative risks. This approach enhances patient outcomes and satisfaction, particularly among older individuals. Additionally, MIGS techniques are frequently performed alongside cataract surgery, offering a dual-benefit solution that is efficient and convenient for patients and providers. With a strong safety profile and effective intraocular pressure (IOP) reduction, MIGS has become an attractive option for managing both early and moderate stages of glaucoma. The growing preference for such procedures is prompting manufacturers to innovate and expand their MIGS device portfolios, solidifying its dominance within the surgical treatment landscape.

Key Market Players
  • Alcon, Inc.
  • Abbott Medical Optics Pvt Ltd
  • Asico LLC
  • Katalyst Surgical LLC
  • Ziemer Ophthalmic Systems AG
  • Lumenis Ltd
  • Iridex Corporation
  • Carl Zeiss Meditec AG
  • Allergan Plc.
  • Glaukos Corporation
Report Scope:

In this report, the Global Glaucoma Surgery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
  • Glaucoma Surgery Devices Market, By Product:
    • Punches, USC marker, USC planner, USC shaver, Forceps, Algerbrush, Probes
    • Diamond knives
    • Glaucoma Drainage Device
    • Laser System
    • Others
  • Glaucoma Surgery Devices Market, By Surgery Method:
    • Traditional glaucoma surgery
    • Minimal invasive glaucoma surgery
    • Laser surgery
  • Glaucoma Surgery Devices Market, By End Use:
    • Hospitals
    • Ophthalmic clinics
    • Others
  • Glaucoma Surgery Devices Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • United Kingdom
      • Italy
      • Germany
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Glaucoma Surgery Devices Market.

Available Customizations:

Global Glaucoma Surgery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. VOICE OF CUSTOMERS

5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product (Punches, USC marker, USC planner, USC shaver, forceps, algerbrush, probes, diamond knives, Glaucoma Drainage Device, Laser System, Others)
  5.2.2. By Surgery Method (Traditional glaucoma surgery, Minimal invasive glaucoma surgery, Laser surgery)
    5.2.2.1. By Traditional glaucoma surgery (Trabeculectomy, Tube shunt surgery)
    5.2.2.2. By Minimal invasive glaucoma surgery (Trabecular meshwork bypass, Suprachoroidal space implants, Subconjunctival space implants)
    5.2.2.3. By Laser surgery (Trabeculoplasty, Iridotomy, Cyclophotocoagulation)
  5.2.3. By End Use (Hospitals, Ophthalmic clinics, Others)
  5.2.4. By Company (2024)
  5.2.5. By Region
5.3. Market Map

6. 6. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product
  6.2.2. By Surgery Method
  6.2.3. By End Use
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Glaucoma Surgery Devices Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Product
      6.3.1.2.2. By Surgery Method
      6.3.1.2.3. By End Use
  6.3.2. Mexico Glaucoma Surgery Devices Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Product
      6.3.2.2.2. By Surgery Method
      6.3.2.2.3. By End Use
  6.3.3. Canada Glaucoma Surgery Devices Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Product
      6.3.3.2.2. By Surgery Method
      6.3.3.2.3. By End Use

7. 7. EUROPE GLAUCOMA SURGERY DEVICES MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Surgery Method
  7.2.3. By End Use
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. France Glaucoma Surgery Devices Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Surgery Method
      7.3.1.2.3. By End Use
  7.3.2. Germany Glaucoma Surgery Devices Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Surgery Method
      7.3.2.2.3. By End Use
  7.3.3. United Kingdom Glaucoma Surgery Devices Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Surgery Method
      7.3.3.2.3. By End Use
  7.3.4. Italy Glaucoma Surgery Devices Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Product
      7.3.4.2.2. By Surgery Method
      7.3.4.2.3. By End Use
  7.3.5. Spain Glaucoma Surgery Devices Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Product
      7.3.5.2.2. By Surgery Method
      7.3.5.2.3. By End Use

8. 8. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Surgery Method
  8.2.3. By End Use
  8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
  8.3.1. China Glaucoma Surgery Devices Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By Surgery Method
      8.3.1.2.3. By End Use
  8.3.2. India Glaucoma Surgery Devices Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By Surgery Method
      8.3.2.2.3. By End Use
  8.3.3. South Korea Glaucoma Surgery Devices Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By Surgery Method
      8.3.3.2.3. By End Use
  8.3.4. Japan Glaucoma Surgery Devices Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By Surgery Method
      8.3.4.2.3. By End Use
  8.3.5. Australia Glaucoma Surgery Devices Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By Surgery Method
      8.3.5.2.3. By End Use

9. 9. SOUTH AMERICA GLAUCOMA SURGERY DEVICES MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Surgery Method
  9.2.3. By End Use
  9.2.4. By Country
9.3. South America: Country Analysis
  9.3.1. Brazil Glaucoma Surgery Devices Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By Surgery Method
      9.3.1.2.3. By End Use
  9.3.2. Argentina Glaucoma Surgery Devices Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By Surgery Method
      9.3.2.2.3. By End Use
  9.3.3. Colombia Glaucoma Surgery Devices Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By Surgery Method
      9.3.3.2.3. By End Use

10. MIDDLE EAST AND AFRICA GLAUCOMA SURGERY DEVICES MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By Surgery Method
  10.2.3. By End Use
  10.2.4. By Country
10.3. MEA: Country Analysis
  10.3.1. South Africa Glaucoma Surgery Devices Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By Surgery Method
      10.3.1.2.3. By End Use
  10.3.2. Saudi Arabia Glaucoma Surgery Devices Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By Surgery Method
      10.3.2.2.3. By End Use
  10.3.3. UAE Glaucoma Surgery Devices Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By Surgery Method
      10.3.3.2.3. By End Use

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. PESTLE ANALYSIS

14. PORTER’S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. COMPETITIVE LANDSCAPE

15.1. Alcon, Inc.
  15.1.1. Business Overview
  15.1.2. Company Snapshot
  15.1.3. Product & Services
  15.1.4. Financials (In case of listed companies)
  15.1.5. Recent Developments
  15.1.6. SWOT Analysis
15.2. Abbott Medical Optics Pvt Ltd
15.3. Asico LLC
15.4. Katalyst Surgical LLC
15.5. Ziemer Ophthalmic Systems AG
15.6. Lumenis Ltd
15.7. Iridex Corporation
15.8. Carl Zeiss Meditec AG
15.9. Allergan Plc.
15.10. Glaukos Corporation

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER


More Publications